Bio Medica Laboratories SME IPO Details, Financials, Valuation & Peers
Explore Bio Medica Laboratories SME IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Overview
Bio Medica Laboratories is a contract manufacturer specializing in pharmaceutical parenteral formulations. The company produces a variety of ethical drugs, generic drugs, and over-the-counter medications in both liquid and dry powder injectable forms. These injectables are available in single-dose and multi-dose formats for human and veterinary healthcare.
Key highlights include:
- Core Business: Contract manufacturing of pharmaceutical parenteral formulations.
- Product Portfolio: Offers 58 liquid injectable products and 15 dry powder injectable products, encompassing generic drugs, branded pharmaceuticals, and OTC medications.
- Industry Focus: Serves both human and veterinary healthcare sectors.
- Quality Certifications: Holds Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificates from the Food & Drugs Administration, Madhya Pradesh.
- Operational Base: Operates two manufacturing facilities in Indore, Madhya Pradesh.
Objects of the Issue
- Repayment of loan
- Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
- General Corporate Purposes
- Total
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 21 May - 25 May 2026 |
| IPO Price Band | ₹132 - ₹139 per share |
| Fresh Issue | ₹44.56 crore |
| Offer For Sale | ₹5.24 crore |
| Total IPO Size | ₹52.43 crore |
| Face Value | ₹10 |
| Listing On | NSE SME |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 21 May 2026 |
| IPO Closing Date | 25 May 2026 |
| Basis Of Allotment | 26 May 2026 |
| Refunds | 27 May 2026 |
| Demat Transfer | 27 May 2026 |
| IPO Listing Date | 29 May 2026 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 | 30 Nov 2025 |
|---|---|---|---|---|
| Assets | 17.57 | 19.53 | 39.12 | 65.17 |
| Total Income | 16.25 | 15.34 | 38.33 | 28.63 |
| Profit After Tax | 0.33 | 2.50 | 9.79 | 8.66 |
| EBITDA | 1.70 | 5.63 | 15.21 | 13.45 |
| NET Worth | 2.44 | 4.94 | 14.73 | 17.12 |
| Reserves and Surplus | 2.34 | 4.84 | 5.55 | 7.94 |
| Total Borrowing | 9.61 | 10.49 | 15.01 | 38.17 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Peer Comparison
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|
| Bio Medica Laboratories Ltd. | 13.03 | 10.67 | 99.59% | 16.05 |
| Shukra Pharmaceuticals Limited | 47.57 | 0.22 | 15.9% | 1.43 |
| Zenotech Laboratories Limited | 0.92 | 6.01% | 15.76 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
IPO Reservation
| Investor Type | Shares Offered |
|---|---|
| Qualified Institutional Buyer (QIB) | 36,000 |
| Non-Institutional Investor (NII/HNI) | 17,55,000 |
| Retail Individual Investor (RII) | 17,92,000 |
Subscription Data from NSE and BSE
As the issue has not yet opened, subscription data is unavailable. However, you can view subscriptions for other ongoing issues here.
IPO Registrar
Skyline Financial Services Private Limited
Phone: 011-40450193-197
Email: ipo@skylinerta.com
Website: www.skylinerta.com
Lead Managers
- 1Narnolia Financial Services Ltd.
Company Address
Bio Medica Laboratories Ltd.Plot No. 11B-11C,
Sector-E, Sanwer Road
Industrial Area, Industrial Estate (Indore),
Indore, – 452015https://www.biomedica.co.in/+91 7314102751companysecretary@biomedica.co.in
FAQs
- What is the issue size of the Bio Medica Laboratories SME IPO?The Bio Medica Laboratories SME IPO has an issue size of ₹52.43 crore. This includes a fresh issue of ₹44.56 crore and an offer for sale (OFS) of ₹5.24 crore.
- What is the price band of the Bio Medica Laboratories IPO?The price band for the Bio Medica Laboratories IPO is ₹132 - ₹139 per share.
- What are the bidding dates for the Bio Medica Laboratories IPO?The Bio Medica Laboratories IPO will open for bidding on 21 May 2026 and close on 25 May 2026.
- What is the allotment date for the Bio Medica Laboratories IPO?The allotment date for the Bio Medica Laboratories IPO is 26 May 2026.
- What is the minimum lot size and investment required for the Bio Medica Laboratories IPO?The minimum lot size for the Bio Medica Laboratories IPO is 1000 shares and the minimum investment required is ₹1,39,000.
- What is the listing date for the Bio Medica Laboratories IPO?The listing date for the Bio Medica Laboratories IPO is 29 May 2026.
- What is the Bio Medica Laboratories IPO grey market premium?The grey market premium (GMP) for the Bio Medica Laboratories IPO is currently at ₹0, with an expected listing gain of approximately 0%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.